Tolerability of NGX-4010, a capsaicin 8% patch for peripheral neuropathic pain

BACKGROUND/PURPOSE: NGX-4010 (QUTENZA(™); NeurogesX Inc, San Mateo, CA), a capsaicin 8% dermal patch, is licensed in the European Union for the treatment of peripheral neuropathic pain (PNP) in nondiabetic adults and in the United States for the treatment of neuropathic pain associated with postherp...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Peppin, John F, Majors, Kristine, Webster, Lynn R, Simpson, David M, Tobias, Jeffrey K, Vanhove, Geertrui F
Format: Artigo
Langue:Inglês
Publié: Dove Medical Press 2011
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3255992/
https://ncbi.nlm.nih.gov/pubmed/22247621
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JPR.S22954
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires